{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:29:13Z","timestamp":1793104153369,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jconrel.2023.08.024","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:39:15Z","timestamp":1694000355000},"page":"381-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pancreatic lipase digestion: The forgotten barrier in oral administration of lipid-based delivery systems?"],"prefix":"10.1016","volume":"362","author":[{"given":"O\u017ebej","family":"Zupan\u010di\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kushwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.08.024_bb0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/17425247.2022.2112173","article-title":"Lipid-based solubilization technology via hot melt extrusion: promises and challenges","volume":"19","author":"Zupan\u010di\u010d","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","article-title":"SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs","volume":"142","author":"Mahmood","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2013.09.010","article-title":"Is the full potential of the biopharmaceutics classification system reached?","volume":"57","author":"Bergstr\u00f6m","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0025","first-page":"413","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2016.04.044","article-title":"Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases","volume":"508","author":"Leonaviciute","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/03639045.2017.1338722","article-title":"Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery","volume":"43","author":"Zupan\u010di\u010d","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0040","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.3109\/10717544.2016.1143056","article-title":"Development and in vitro evaluation of an oral SEDDS for desmopressin","volume":"23","author":"Zupan\u010di\u010d","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejps.2015.10.005","article-title":"Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin","volume":"81","author":"Zupan\u010di\u010d","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijpharm.2017.03.027","article-title":"Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione","volume":"523","author":"Het\u00e9nyi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0055","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/17425247.2016.1167034","article-title":"Development of oral self nano-emulsifying delivery system(s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions","volume":"13","author":"Ijaz","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2014.08.004","article-title":"Pre-systemic metabolism of orally administered drugs and strategies to overcome it","volume":"192","author":"Sousa","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejps.2014.06.008","article-title":"Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug","volume":"62","author":"Zhang","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1208\/s12249-015-0365-2","article-title":"Abbas, pH-dependent solubility and dissolution behavior of carvedilol\u2014case example of a weakly basic BCS class II drug","volume":"17","author":"Hamed","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2019.04.038","article-title":"Effect of lipids on absorption of carvedilol in dogs: is coadministration of lipids as efficient as a lipid-based formulation?","volume":"304","author":"Alsk\u00e4r","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40005-022-00574-y","article-title":"Alginate-coated chitosan nanoparticles protect protein drugs from acid degradation in gastric media","volume":"52","author":"Tran","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0085","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2217\/nnm.13.178","article-title":"Strategies for improving mucosal drug delivery","volume":"8","author":"Laffleur","year":"2013","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0090","doi-asserted-by":"crossref","first-page":"2000247","DOI":"10.1002\/adtp.202000247","article-title":"Overcoming the mucosal barrier: tetraether lipid-stabilized liposomal nanocarriers decorated with cell-penetrating peptides enable oral delivery of vancomycin","volume":"4","author":"Uhl","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-bioeng-062117-121156","article-title":"Engineering the mucus barrier","volume":"20","author":"Carlson","year":"2018","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0110","article-title":"Biological chemotaxis-guided self-thermophoretic nanoplatform augments colorectal cancer therapy through autonomous mucus penetration","volume":"8","author":"Wang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0115","doi-asserted-by":"crossref","first-page":"2212013","DOI":"10.1002\/adfm.202212013","article-title":"Self-thermophoretic nanoparticles enhance intestinal mucus penetration and reduce pathogenic Bacteria interception in colorectal cancer","volume":"33","author":"Wang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0120","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u201cself-microemulsifying\u201d drug delivery systems","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci., Elsevier"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0130","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Mol."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0135","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/app13031726","article-title":"Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives","volume":"13","author":"Tang","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117145","article-title":"Lipid shell lipid nanocapsules as smart generation lipid nanocarriers","volume":"339","author":"Dabholkar","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40005-014-0165-9","article-title":"Lyotropic liquid crystal systems in drug delivery: a review","volume":"45","author":"Kim","year":"2015","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcis.2012.10.014","article-title":"Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions","volume":"393","author":"Mulet","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0160","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3389\/fnut.2021.783831","article-title":"A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems","volume":"8","author":"Lu","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0165","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/pharmaceutics14040836","article-title":"Lipid-based nanocarriers for neurological disorders: a review of the state-of-the-art and therapeutic success to date","volume":"14","author":"Witika","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0170","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/pharmaceutics14040831","article-title":"Fundamental aspects of lipid-based excipients in lipid-based product development","volume":"14","author":"Nakmode","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0175","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","article-title":"Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0180","series-title":"Successful Development of Oral SEDDS: Screening of Excipients from the Industrial Point of View","author":"Nardin","year":"2019"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4155\/tde.11.138","article-title":"Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems","volume":"3","author":"N\u2019Goma","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2019.06.010","article-title":"In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends","volume":"142","author":"Berthelsen","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119115","article-title":"Pancreatic lipase inhibitors: the road voyaged and successes","volume":"271","author":"Kumar","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0200","first-page":"156","article-title":"Lipases and lipolysis in the human digestive tract: where do we stand?","volume":"10","author":"Armand","year":"2007","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0205","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0016-5085(93)90908-U","article-title":"Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans","volume":"105","author":"Carriere","year":"1993","journal-title":"Gastroenterology."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0210","first-page":"756","article-title":"Upper gastrointestinal (GI) pH in young, healthy men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbalip.2008.05.006","article-title":"Lipolysis of the semi-solid self-emulsifying excipient Gelucire\u00ae 44\/14 by digestive lipases","volume":"1781","author":"Fernandez","year":"2008","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0220","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.M600486-JLR200","article-title":"Further biochemical characterization of human pancreatic lipase-related protein 2 expressed in yeast cells","volume":"48","author":"Eydoux","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0304-4157(98)00016-1","article-title":"Structural basis for the substrate selectivity of pancreatic lipases and some related proteins","volume":"1376","author":"Carri\u00e8re","year":"1998","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0230","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1194\/jlr.M400509-JLR200","article-title":"Continuous monitoring of cholesterol oleate hydrolysis by hormone-sensitive lipase and other cholesterol esterases","volume":"46","author":"Ben Ali","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0235","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbalip.2009.05.002","article-title":"Continuous measurement of galactolipid hydrolysis by pancreatic lipolytic enzymes using the pH-stat technique and a medium chain monogalactosyl diglyceride as substrate","volume":"1791","author":"Amara","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0240","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbalip.2007.02.009","article-title":"Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol\u00ae, medium chain glycerides and PEG esters","volume":"1771","author":"Fernandez","year":"2007","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2022.05.003","article-title":"Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin","volume":"176","author":"Z\u00f6ller","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jps.10554","article-title":"Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach","volume":"93","author":"Kossena","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0260","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3109\/03639045.2011.645834","article-title":"In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life","volume":"38","author":"Arnold","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0265","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/acs.molpharmaceut.0c00305","article-title":"Exploring the impact of surfactant type and digestion: highly digestible surfactants improve oral bioavailability of nilotinib","volume":"17","author":"Koehl","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1211\/0022357021771896","article-title":"Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products","volume":"54","author":"Sek","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0275","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jps.21246","article-title":"Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs","volume":"97","author":"Cuin\u00e9","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0280","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1208\/s12249-012-9787-2","article-title":"Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion","volume":"13","author":"Mohsin","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0285","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, Part 1: Method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0290","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/B:PHAM.0000036914.22132.cc","article-title":"Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation","volume":"21","author":"Porter","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0295","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1002\/jps.21659","article-title":"Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution","volume":"98","author":"Mohsin","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0300","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpb.2015.04.027","article-title":"Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis","volume":"93","author":"Benito-Gallo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2017.03.393","article-title":"In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems","volume":"255","author":"Tran","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0310","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/02652048.2015.1035685","article-title":"Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release","volume":"32","author":"Mahjub","year":"2015","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0315","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/jps.24634","article-title":"In situ lipolysis and synchrotron small-angle X-ray scattering for the direct determination of the precipitation and solid-state form of a poorly water-soluble drug during digestion of a lipid-based formulation","volume":"105","author":"Khan","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0320","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/jps.23892","article-title":"Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations","volume":"103","author":"Stillhart","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0325","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tifs.2019.12.015","article-title":"Current in vitro digestion systems for understanding food digestion in human upper gastrointestinal tract","volume":"96","author":"Li","year":"2020","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0330","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.foodres.2016.10.049","article-title":"Development of an in vitro mechanical gastric system (IMGS) with realistic peristalsis to assess lipid digestibility","volume":"90","author":"Barros","year":"2016","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0335","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14227\/DT260219P20","article-title":"Design of an innovative advanced gastric simulator","volume":"26","author":"Hribar","year":"2019","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0340","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.1111\/j.1750-3841.2010.01856.x","article-title":"A human gastric simulator (HGS) to study food digestion in human stomach","volume":"75","author":"Kong","year":"2010","journal-title":"J. Food Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0345","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3136\/fstr.20.225","article-title":"Development of a human gastric digestion simulator equipped with peristalsis function for the direct observation and analysis of the food digestion process","volume":"20","author":"Kozu","year":"2014","journal-title":"Food Sci. Technol. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lwt.2016.01.030","article-title":"Improved emulsifying capabilities of hydrolysates of soy protein isolate pretreated with high pressure microfluidization","volume":"69","author":"Chen","year":"2016","journal-title":"LWT."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0355","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1039\/C8FO02586J","article-title":"An advanced near real dynamic: in vitro human stomach system to study gastric digestion and emptying of beef stew and cooked rice","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0360","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1208\/s12249-011-9616-z","article-title":"Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data","volume":"12","author":"Vardakou","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0365","first-page":"15","article-title":"The design, operation, and application of a dynamic gastric model","volume":"19","author":"Wickham","year":"2012","journal-title":"Dissolutiontech.Com."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0370","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41596-018-0119-1","article-title":"INFOGEST static in vitro simulation of gastrointestinal food digestion","volume":"14","author":"Brodkorb","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0375","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.foodchem.2017.05.081","article-title":"In vitro gastric digestion of cooked white and brown rice using a dynamic rat stomach model","volume":"237","author":"Wu","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0380","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/1750-3841.13683","article-title":"Enhancement of digestibility of casein powder and raw rice particles in an improved dynamic rat stomach model through an additional rolling mechanism","volume":"82","author":"Wu","year":"2017","journal-title":"J. Food Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0385","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jfoodeng.2014.06.010","article-title":"Digestive behaviours of large raw rice particles in vivo and in vitro rat stomach systems","volume":"142","author":"Wu","year":"2014","journal-title":"J. Food Eng."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0390","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1039\/C4FO01045K","article-title":"Effects of inhomogeneity on triglyceride digestion of emulsions using an: in vitro digestion model (Tiny TIM)","volume":"7","author":"Oosterveld","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.foodchem.2013.07.073","article-title":"Effects of a high fat meal matrix and protein complexation on the bioaccessibility of blueberry anthocyanins using the TNO gastrointestinal model (TIM-1)","volume":"142","author":"Ribnicky","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0400","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2015.11.048","article-title":"Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms","volume":"498","author":"Verwei","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/026119299502300205","article-title":"A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine","volume":"23","author":"Minekus","year":"1995","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122042","article-title":"Optimization of dissolution compartments in a biorelevant dissolution apparatus golem v2, supported by multivariate analysis","volume":"22","author":"Stup\u00e1k","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0415","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/328628","article-title":"Development of in vitro - in vivo correlation\/relationship modeling approaches for immediate release formulations using compartmental dynamic dissolution data from \u201cgolem\u201d: a novel apparatus","volume":"2015","author":"\u010culen","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0420","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jff.2014.09.019","article-title":"Prebiotic effects of cassava bagasse in TNO\u2019s in vitro model of the colon in lean versus obese microbiota","volume":"11","author":"Bussolo de Souza","year":"2014","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.130233","article-title":"The bioavailability of soybean polysaccharides and their metabolites on gut microbiota in the simulator of the human intestinal microbial ecosystem (SHIME)","volume":"362","author":"Chen","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0430","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.foodres.2017.12.049","article-title":"Digestion of milk proteins: comparing static and dynamic in vitro digestion systems with in vivo data","volume":"118","author":"Egger","year":"2019","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0435","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.xphs.2016.12.026","article-title":"High-throughput lipolysis in 96-well plates for rapid screening of lipid-based drug delivery systems","volume":"106","author":"Mosgaard","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0440","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejpb.2015.06.028","article-title":"Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems","volume":"94","author":"Mosgaard","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0445","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11095-006-9054-x","article-title":"Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats","volume":"23","author":"Dahan","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0450","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.23054","article-title":"Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems","volume":"101","author":"Thomas","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0455","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s11095-008-9641-0","article-title":"Lipid-based formulations for danazol containing a digestible surfactant, labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis","author":"Larsen","year":"2008","journal-title":"Pharm. Res., Springer"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0460","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejps.2007.02.009","article-title":"Morphological observations on a lipid-based drug delivery system during in vitro digestion","volume":"31","author":"Fatouros","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0465","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2011.03.002","article-title":"In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems","volume":"417","author":"Larsen","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13228-011-0014-5","article-title":"In vitro gastrointestinal lipolysis: replacement of human digestive lipases by a combination of rabbit gastric and porcine pancreatic extracts","volume":"2","author":"Capolino","year":"2011","journal-title":"Food Dig."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0475","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1208\/s12248-012-9398-6","article-title":"Characterising lipid lipolysis and its implication in lipid-based formulation development","volume":"14","author":"Thomas","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0480","first-page":"1344","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels","volume":"16","author":"Sassene","year":"2014","journal-title":"Bot. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0485","doi-asserted-by":"crossref","first-page":"28070","DOI":"10.1074\/jbc.M202839200","article-title":"Mechanisms of inhibition of triacylglycerol hydrolysis by human gastric lipase","volume":"277","author":"Pafumi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(01)00182-8","article-title":"A dynamic in vitro lipolysis model. II: evaluation of the model","volume":"14","author":"Zangenberg","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0495","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/mp300331z","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. the effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion","volume":"9","author":"Williams","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0500","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s11095-013-1038-z","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: Understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations","volume":"30","author":"Williams","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0505","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/jps.24067","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system","volume":"103","author":"Williams","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0510","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11095-014-1532-y","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase","volume":"32","author":"Bakala-N\u2019Goma","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0515","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1039\/c0fo00111b","article-title":"Review of in vitro digestion models for rapid screening of emulsion-based systems","volume":"1","author":"McClements","year":"2010","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0520","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0525","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2017.05.001","article-title":"Simultaneous lipolysis\/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems","volume":"117","author":"Bibi","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-017-2327-8","article-title":"Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations","volume":"35","author":"Keemink","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0535","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.molpharmaceut.8b00811","article-title":"Lipolysis-permeation setup for simultaneous study of digestion and absorption in vitro","volume":"16","author":"Keemink","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0540","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/C5FO00930H","article-title":"Relevant pH and lipase for in vitro models of gastric digestion","volume":"7","author":"Sams","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0545","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1208\/s12248-014-9589-4","article-title":"In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate","volume":"16","author":"Thomas","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0550","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1002\/hep.1840040814","article-title":"The ionization behavior of fatty acids and bile acids in micelles and membranes","volume":"4","author":"Small","year":"1984","journal-title":"Hepatology."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0555","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1039\/C6FO00158K","article-title":"Comparison of lipases for in vitro models of gastric digestion: lipolysis using two infant formulas as model substrates","volume":"7","author":"Sassene","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0560","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.drudis.2007.07.024","article-title":"Pancreatic lipase inhibitors from natural sources: unexplored potential","volume":"12","author":"Birari","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0565","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1055\/s-0035-1546173","article-title":"Polyphenolic compounds as pancreatic lipase inhibitors","volume":"81","author":"Buchholz","year":"2015","journal-title":"Planta Med."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0570","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1021\/jf0628025","article-title":"Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor","volume":"55","author":"Karu","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0575","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.ijo.0801747","article-title":"Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor","volume":"25","author":"Han","year":"2001","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0580","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00044-017-1836-7","article-title":"Bis-indole alkaloids from Tabernaemontana divaricata as potent pancreatic lipase inhibitors: molecular modelling studies and experimental validation","volume":"26","author":"Sridhar","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0585","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.apjtb.2015.09.012","article-title":"Screening for anti-pancreatic lipase properties of 28 traditional Thai medicinal herbs","volume":"5","author":"Dechakhamphu","year":"2015","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0590","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/14756366.2010.525509","article-title":"Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba","volume":"26","author":"Bustanji","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0595","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.foodchem.2017.09.075","article-title":"Identification and biological activities of carotenoids from the freshwater alga Oedogonium intermedium","volume":"242","author":"Wang","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0600","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.phytochem.2010.08.009","article-title":"A lipase inhibitor monoterpene and monoterpene glycosides from Monarda punctata","volume":"71","author":"Yamada","year":"2010","journal-title":"Phytochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0605","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.ijbiomac.2018.07.085","article-title":"Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: inhibition potentials and mechanism","volume":"118","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0610","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.7164\/antibiotics.47.1369","article-title":"Panclicins, novel pancreatic lipase inhibitors. I. Taxonomy, fermentation, isolation and biological activity","volume":"47","author":"Mutoh","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1893-y","article-title":"Fungal endophytes associated with Viola odorata Linn. as bioresource for pancreatic lipase inhibitors","volume":"17","author":"Katoch","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110314","article-title":"Lipase inhibitors for obesity: A review","volume":"128","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0625","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1573408017666210121114441","article-title":"A review on pancreatic lipase inhibitors from natural sources: a potential target for obesity","volume":"17","author":"Bency Baby","year":"2021","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0630","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.sajb.2018.04.004","article-title":"Therapeutic role of lipases and lipase inhibitors derived from natural resources for remedies against metabolic disorders and lifestyle diseases","volume":"120","author":"Jawed","year":"2019","journal-title":"South African J. Bot."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0635","series-title":"IOP Conf. Ser. Mater. Sci. Eng","first-page":"012063","article-title":"Review of the clinical effect of orlistat","author":"Qi","year":"2018"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121958","article-title":"Controlling drug release by introducing lipase inhibitor within a lipid formulation","volume":"623","author":"Murshed","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0645","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcis.2020.04.015","article-title":"Modulating the release of pharmaceuticals from lipid cubic phases using a lipase inhibitor","volume":"573","author":"Dully","year":"2020","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0650","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1208\/s12248-015-9832-7","article-title":"The effect of digestion and drug load on halofantrine absorption from self-nanoemulsifying drug delivery system (SNEDDS)","volume":"18","author":"Michaelsen","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0655","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2003.10.036","article-title":"Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility","volume":"270","author":"De Smidt","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0660","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s11095-010-0362-9","article-title":"Effects of surfactants on lipase structure, activity, and inhibition","volume":"28","author":"Delorme","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0665","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1109\/MEI.1998.714652","article-title":"Surfactants and polymers in aqueous solutions","volume":"14","author":"Jonsson","year":"1998","journal-title":"IEEE Electr. Insul. Mag."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0670","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejpb.2011.03.019","article-title":"Inhibition of lipase-catalyzed hydrolysis of emulsified triglyceride oils by low-molecular weight surfactants under simulated gastrointestinal conditions","volume":"79","author":"Li","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0675","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1021\/bi049479o","article-title":"Might the kinetic behavior of hormone-sensitive lipase reflect the absence of the lid domain?","volume":"43","author":"Ben Ali","year":"2004","journal-title":"Biochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0680","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/bi00218a022","article-title":"Inactivation of gastric and pancreatic lipases by diethyl p-nitrophenyl phosphate","volume":"30","author":"Moreau","year":"1991","journal-title":"Biochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0685","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1021\/bi00213a008","article-title":"Inactivation of pancreatic lipases by amphiphilic reagents 5-(Dodecyldithio)-2-nitrobenzoic acid and Tetrahydrolipstatin. dependence upon partitioning between micellar and oil phases","volume":"32","author":"Cudrey","year":"1993","journal-title":"Biochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0690","series-title":"Lipases Phospholipases Drug Dev","first-page":"155","article-title":"Lipases and phospholipases in drug development: from biochemistry to molecular pharmacology","year":"2004"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0695","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1432-1033.1992.tb16791.x","article-title":"Large spectral changes accompany the conformational transition of human pancreatic lipase induced by acylation with the inhibitor tetrahydrolipstatin","volume":"205","author":"L\u00fcthi-Peng","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0700","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1432-1033.1994.tb18878.x","article-title":"Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat)","volume":"222","author":"Lookene","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0705","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0005-2760(91)90136-6","article-title":"Inactivation of pancreatic and gastric lipases by THL and C12:0-TNB: a kinetic study with emulsified tributyrin","volume":"1085","author":"Gargouri","year":"1991","journal-title":"Biochim. Biophys. Acta (BBA)\/Lipids Lipid Metab."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0710","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1021\/bi002202d","article-title":"The closed\/open model for lipase activation. Addressing intermediate active forms of fungal enzymes by trapping of conformers in water-restricted environments","volume":"40","author":"Gonz\u00e1lez-Navarro","year":"2001","journal-title":"Biochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0715","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1074\/jbc.271.30.18007","article-title":"Lipase activation by nonionic detergents. The crystal structure of the porcine lipase-colipase-tetraethylene glycol monooctyl ether complex","volume":"271","author":"Hermoso","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0720","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-2275(20)37884-6","article-title":"Studies on the detergent inhibition of pancreatic lipase activity","volume":"24","author":"Gargouri","year":"1983","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0725","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-7799(91)90064-O","article-title":"Protein adsorption to solid surfaces","volume":"9","author":"Wahlgren","year":"1991","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0730","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1021\/bi982601x","article-title":"Human pancreatic lipase: colipase dependence and interfacial binding of lid domain mutants","volume":"38","author":"Bezzine","year":"1999","journal-title":"Biochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0735","series-title":"Lipases Phospholipases Drug Dev","first-page":"195","article-title":"Physiology of gastrointestinal lipolysis and therapeutical use of lipases and digestive lipase inhibitors","author":"Lengsfeld","year":"2005"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0740","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.bbalip.2007.10.006","article-title":"A comparative study on two fungal lipases from Thermomyces lanuginosus and Yarrowia lipolytica shows the combined effects of detergents and pH on lipase adsorption and activity","volume":"1771","author":"Aloulou","year":"2007","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0745","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/bi0518803","article-title":"How gastric lipase, an interfacial enzyme with a Ser-His-Asp catalytic triad, acts optimally at acidic pH","volume":"45","author":"Chahinian","year":"2006","journal-title":"Biochemistry."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2020.106163","article-title":"Lipolysis products formation during in vitro gastric digestion is affected by the emulsion interfacial composition","volume":"110","author":"Infantes-Garcia","year":"2021","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0755","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbalip.2006.06.009","article-title":"Exploring the specific features of interfacial enzymology based on lipase studies","volume":"1761","author":"Aloulou","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0760","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-2275(20)41747-X","article-title":"Interactions of pancreatic lipase with bile salts and dodecyl sulfate","volume":"17","author":"Borgstrom","year":"1976","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0765","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1432-1033.1986.tb09583.x","article-title":"Human gastric lipase: the effect of amphiphiles","volume":"156","author":"Gargouri","year":"1986","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0770","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2014.07.037","article-title":"\u201cStealth\u201d lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug","volume":"192","author":"Feeney","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0775","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1021\/mp400176y","article-title":"Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability","volume":"10","author":"Childs","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0780","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2011.12.025","article-title":"Controlling lipolysis through steric surfactants: new insights on the controlled degradation of submicron emulsions after oral and intravenous administration","volume":"423","author":"Wulff-P\u00e9rez","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0785","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.foodchem.2017.06.137","article-title":"Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers","volume":"239","author":"Ban","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0795","series-title":"Colloid. Biomol. Biomater. Biomed. Appl","first-page":"309","article-title":"Colloidal biomolecules, biomaterials, and biomedical applications","author":"Elaissari","year":"2003"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0800","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1201\/9780203739754-12","article-title":"Ternary phase behavior of mixtures of siloxane surfactants","author":"Hill","year":"2019","journal-title":"Silicone Oils, and Water, Silicone Surfactants."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0805","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00394-009-0078-y","article-title":"Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats","volume":"49","author":"Matsumoto","year":"2010","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0810","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jff.2015.05.035","article-title":"In vitro and in vivo study of fucoxanthin bioavailability from nanoemulsion-based delivery systems: impact of lipid carrier type","volume":"17","author":"Salvia-Trujillo","year":"2015","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0815","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","article-title":"A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms","volume":"31","author":"Tuvia","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.024_bb0820","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2018.01.012","article-title":"Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs","volume":"273","author":"Bonengel","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.024_bb0825","article-title":"Development and in vivo evaluation of nanoemulsions for oral delivery of low molecular weight heparin","volume":"86","author":"Z\u00f6ller","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:49:37Z","timestamp":1759164577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923005229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":165,"alternative-id":["S0168365923005229"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic lipase digestion: The forgotten barrier in oral administration of lipid-based delivery systems?","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}